The role of ubiquitination in tumorigenesis and targeted drug discovery

L Deng, T Meng, L Chen, W Wei, P Wang - Signal transduction and …, 2020 - nature.com
Ubiquitination, an important type of protein posttranslational modification (PTM), plays a
crucial role in controlling substrate degradation and subsequently mediates the “quantity” …

Genetics and biology of prostate cancer

G Wang, D Zhao, DJ Spring… - Genes & …, 2018 - genesdev.cshlp.org
Despite the high long-term survival in localized prostate cancer, metastatic prostate cancer
remains largely incurable even after intensive multimodal therapy. The lethality of advanced …

The long tail of oncogenic drivers in prostate cancer

J Armenia, SAM Wankowicz, D Liu, J Gao, R Kundra… - Nature …, 2018 - nature.com
Comprehensive genomic characterization of prostate cancer has identified recurrent
alterations in genes involved in androgen signaling, DNA repair, and PI3K signaling, among …

Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer

H Beltran, D Prandi, JM Mosquera, M Benelli, L Puca… - Nature medicine, 2016 - nature.com
An increasingly recognized resistance mechanism to androgen receptor (AR)-directed
therapy in prostate cancer involves epithelial plasticity, in which tumor cells demonstrate low …

Cancer mutations of the tumor suppressor SPOP disrupt the formation of active, phase-separated compartments

JJ Bouchard, JH Otero, DC Scott, E Szulc, EW Martin… - Molecular cell, 2018 - cell.com
Mutations in the tumor suppressor SPOP (speckle-type POZ protein) cause prostate, breast,
and other solid tumors. SPOP is a substrate adaptor of the cullin3-RING ubiquitin ligase and …

Prostate cancer–associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4

X Dai, W Gan, X Li, S Wang, W Zhang, L Huang… - Nature medicine, 2017 - nature.com
The bromodomain and extraterminal (BET) family of proteins comprises four members—
BRD2, BRD3, BRD4 and the testis-specific isoform BRDT—that largely function as …

TRIM24 is an oncogenic transcriptional activator in prostate cancer

AC Groner, L Cato, J de Tribolet-Hardy, T Bernasocchi… - Cancer cell, 2016 - cell.com
Androgen receptor (AR) signaling is a key driver of prostate cancer (PC). While androgen-
deprivation therapy is transiently effective in advanced disease, tumors often progress to a …

Higher-order SPOP assembly reveals a basis for cancer mutant dysregulation

MJ Cuneo, BG O'Flynn, YH Lo, N Sabri, T Mittag - Molecular cell, 2023 - cell.com
The speckle-type POZ protein (SPOP) functions in the Cullin3-RING ubiquitin ligase (CRL3)
as a receptor for the recognition of substrates involved in cell growth, survival, and signaling …

SPOP mutation drives prostate tumorigenesis in vivo through coordinate regulation of PI3K/mTOR and AR signaling

M Blattner, D Liu, BD Robinson, D Huang, A Poliakov… - Cancer cell, 2017 - cell.com
Recurrent point mutations in SPOP define a distinct molecular subclass of prostate cancer.
Here, we describe a mouse model showing that mutant SPOP drives prostate tumorigenesis …

Comprehensive assessment of cancer missense mutation clustering in protein structures

A Kamburov, MS Lawrence, P Polak… - Proceedings of the …, 2015 - National Acad Sciences
Large-scale tumor sequencing projects enabled the identification of many new cancer gene
candidates through computational approaches. Here, we describe a general method to …